Pharmacology of Rapid-acting Insulin Injected by Needle-free Jet-injection in Patients With Diabetes.

Trial Profile

Pharmacology of Rapid-acting Insulin Injected by Needle-free Jet-injection in Patients With Diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Sep 2013

At a glance

  • Drugs Insulin aspart (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 03 Oct 2011 Actual initiation date (September 2011) added as reported by ClinicalTrials.gov.
    • 03 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top